Immunopharmacologic response of patients with B-lineage acute lymphoblastic leukemia to continuous infusion of T cell-engaging CD19/CD3-bispecific BiTE antibody blinatumomab

Defining the correct role of minimal residual disease tests in the management of acute lymphoblastic leukaemia

(2011) Giovanni Cazzaniga et al.   BRITISH JOURNAL OF HAEMATOLOGY

Ipilimumab: An Anti-CTLA-4 Antibody for Metastatic Melanoma

(2011) E. J. Lipson et al.   CLINICAL CANCER RESEARCH

Immunomodulatory therapy of cancer with T cell-engaging BiTE antibody blinatumomab

(2011) Dirk Nagorsen et al.   EXPERIMENTAL CELL RESEARCH

Clinical peptide vaccination trials for leukemia patients

(2011) R Casalegno-Garduño et al.   Expert Review of Vaccines

Melanoma vaccines: developments over the past 10 years

(2011) Oliver Klein et al.   Expert Review of Vaccines

Current status and future applications of cellular therapies for cancer

(2011) John Copier et al.   Immunotherapy

Targeted Therapy With the T-Cell–Engaging Antibody Blinatumomab of Chemotherapy-Refractory Minimal Residual Disease in B-Lineage Acute Lymphoblastic Leukemia Patients Results in High Response Rate and Prolonged Leukemia-Free Survival

(2011) Max S. Topp et al.   JOURNAL OF CLINICAL ONCOLOGY

Recent Developments in Cancer Vaccines

(2011) K. Palucka et al.   JOURNAL OF IMMUNOLOGY

Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia

(2011) David L. Porter et al.   NEW ENGLAND JOURNAL OF MEDICINE

Focus on Adoptive T Cell Transfer Trials in Melanoma

(2010) Liat Hershkovitz et al.   Clinical & Developmental Immunology

Targeting cytotoxic T-lymphocyte antigen 4 in immunotherapies for melanoma and other cancers

(2010) David B Page et al.   Immunotherapy

Clinical significance of minimal residual disease in adult acute lymphoblastic leukemia

(2010) Misato Kikuchi et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Mode of cytotoxic action of T cell-engaging BiTE antibody MT110

(2009) Cornelia Haas et al.   IMMUNOBIOLOGY

Potent Control of Tumor Growth by CEA/CD3-bispecific Single-chain Antibody Constructs That Are Not Competitively Inhibited by Soluble CEA

(2009) Ralf Lutterbuese et al.   JOURNAL OF IMMUNOTHERAPY

Biochemical signaling pathways for memory T cell recall

(2009) Donna L. Farber   SEMINARS IN IMMUNOLOGY

Tumor Regression in Cancer Patients by Very Low Doses of a T Cell-Engaging Antibody

(2008) R. Bargou et al.   SCIENCE